1. Home
  2. News
  3. New capacity increase to conduct stability studies at Labofine
Labofine

New capacity increase to conduct stability studies at Labofine

Critical for Quality, Therapeutic Activity and Safety

 

Labofine – a Tentamus company has announced today that it has added state-of-the-art, fully mapped walk-in stability chambers in its new Montreal area location, situated at 5600 Trans-Canada Hwy, Quebec, Canada.

“This is welcome news for our local and international clients”, said Dr. M. Mancini, Labofine’s Director of Corporate Development, “since it increases our capacity to provide storage conditions for long-term, accelerated or intermediate studies for the three classes of label storage claims and the conditions required by the five climatic zones meeting ICH and WHO guidelines.”

“By adding state-of-the-art equipment, we are beyond excited to continue building momentum with our expansion, which we believe is an excellent representation of the way Labofine views our partnerships with our customers,” added CEO Dr. G. Sammane.

Labofine first entered the Canadian testing market in 2014 with the opening of its Laval, Quebec location. Since then, it has seen tremendous growth, including the opening of operations in California in 2017 to offer extensive coverage of the North American market. After joining the Tentamus Group in 2019, Labofine continues to expand its reach to better serve its Canadian customers in the domain of supplements, pharmaceuticals, cosmetics and food products.

 

Contact: 

Rosanne Bizarro
Customer Service Manager
rosanne@labofine.com

Tentamus laboratories in your vicinity